Work

Abstract 4188: RNAi and CRISPR/Cas9 based in vivo models for drug discovery

Year: 2016

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2016-4188

Authors: Prem K. Premsrirut, Gregory Martin, Lukas Dow, Sang Yong Kim, Johannes Zuber, Scott Lowe, Greg Hannon

Institutions: Charles River Laboratories (United States), Weill Cornell Medicine, New York University, Research Institute of Molecular Pathology, Memorial Sloan Kettering Cancer Center, Cancer Research UK, Cancer Research UK Cambridge Center

Language: English

Topic: CRISPR and Genetic Engineering

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2806318200

Cites:

Cited by: 1

Related to: 10